| CTNT 0.04 -10.11% | ALP 0.23 -17.86% | FFAI 0.4232 -20.44% | TZA 5.04 -1.95% | BYND 1.1 5.26% | SOXS 16.8 -7.69% | NVDA 202.5 1.31% | NOK 9.825 -5.53% | BITO 10.82 5.15% | INTC 65.27 -1.49% | POET 12.77 24.59% | NVTS 18.47 20.48% | AGPU 8.75 79.30% | BMNG 1.64 14.69% | QVCGA 0.447 11.06% | TQQQ 60.21 4.90% | ONDS 11.06 1.75% | PLUG 3.19 3.57% | ASBP 0.2224 13.01% | AAL 11.5 -2.29% | BURU 0.2811 8.03% | CGC 1.38 21.05% | SOXL 105.64 7.70% | MSOS 5.11 19.39% | SMR 13.58 16.37% | FRMI 5.86 15.81% | TSLA 387.51 0.28% | T 25.97 0.35% | SQQQ 54.73 -4.97% | MARA 11.84 5.43% | IBIT 44.75 5.27% | AMD 303.46 6.67% | TDTH 0.0774 3.48% | BMNR 23.31 7.37% | TSLL 12.93 0.47% | NVD 5.56 -2.63% | MU 487.48 8.48% | SOFI 19.06 1.22% | PLTR 152.62 4.56% | OPEN 5.43 -0.37% | AAPL 273.17 2.63% | GAME 0.6069 33.86% | GPUS 0.1712 11.17% | SPY 711.21 1.01% | BSX 64.87 8.99% | AKAN 10.21 214.15% | SPDN 9.11 -0.98% | GRAB 4.06 -0.49% | BBD 4.04 -0.74% | CPNG 20.6 0.93%

Insider Selling at Arteris, Inc. (NASDAQ:AIP) Raises Questions

Arteris, Inc. (NASDAQ:AIP) operates in the semiconductor industry, providing network-on-chip (NoC) interconnect IP solutions. These solutions are crucial for the design and development of complex system-on-chip (SoC) architectures. Arteris competes with other semiconductor companies that offer similar IP solutions, such as Synopsys and Cadence Design Systems.

On March 4, 2026, Raza Saiyed Atiq, a director at Arteris, executed a sale of 3,690 shares of the company's common stock at approximately $17.02 per share. This transaction follows a series of sales by Raza, including a significant sale of 73,610 shares on February 26th at an average price of $17.14 per share, totaling around $1.26 million. These sales have reduced Raza's holdings in the company by 12.58%.

Despite these sales, Raza still holds a substantial number of shares, with 390,000 shares remaining after the March 4th transaction. Prior to this, Raza had 511,483 shares valued at approximately $8.77 million. The recent sales reflect a strategic reduction in Raza's position, possibly influenced by the company's current financial metrics.

Arteris' stock opened at $16.99 following these transactions, showing a 1.3% decrease. The stock has fluctuated between a 12-month low of $5.46 and a high of $17.14. The company's financial metrics reveal challenges, with a negative price-to-earnings (P/E) ratio of -20.71, indicating negative earnings. The price-to-sales ratio is 10.60, and the enterprise value to sales ratio is 10.25, suggesting a high valuation relative to sales.

The company's financial health is further highlighted by a negative earnings yield of -4.83% and a debt-to-equity ratio of -0.62, indicating more equity than debt, which is unusual and may suggest negative equity. The current ratio of 1.13 suggests a reasonable level of short-term liquidity, with current assets slightly exceeding current liabilities. These metrics provide insight into the company's financial position amidst the recent insider selling activity.

Published on: March 5, 2026